Ankush S.

Life sciences strategy consultant with 4+ years advising US and EU biopharma on competitive intelligence, forecasting, and commercial strategy across oncology, neurology, and rare disease.
I build epidemiology-based and patient-based forecasting models and risk-adjusted NPV analyses that inform portfolio and investment decisions, and I lead indication prioritization, market entry, and commercial due diligence engagements. My work has supported 6 of the top 10 global pharma companies.
Earlier, at Mordor Intelligence, I held a 90% proposal win rate against a 60% team average across 130+ bespoke mandates, and was selected among the top 1% of analysts for the firm’s quality oversight program.
I work fluently across IQVIA MIDAS, Citeline, Evaluate Pharma, CapitalIQ, Alteryx, Tableau, Power BI, and SQL, and I turn ambiguous business questions into clear, client-ready deliverables. Available for remote engagements on US and European hours.